Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Cirrus Logic have rebounded after tanking yesterday, enjoying gains as high as 13% today after reporting earnings.
So what: Yesterday's plunge was related to Apple's earnings, since the iPhone maker is Cirrus Logic's largest customer and investors were disappointed in iPhone sales. That fear was misplaced, as revenue in the fourth quarter skyrocketed 153% to $310 million, shattering the consensus estimate of $285 million.
Now what: The top line similarly crushed forecasts, with the $1.64 per share profit blowing past the Street's best guesses of $1.41 per share. The company expects the current quarter to see sales of $200 million to $220 million, with gross margin of 50% to 52%. That top line outlook represents 80% growth from a year prior, which, while less than the growth it just posted, is nothing for investors to complain about.
Interested in more info on Cirrus? Add it to your watchlist by clicking here.
2013 and beyond
The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.
The article Why Cirrus Logic Shares Rebounded With a Vengeance originally appeared on Fool.com.Fool contributor Evan Niu, CFA, owns shares of Apple. The Motley Fool recommends Apple. The Motley Fool owns shares of Apple and Cirrus Logic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.